ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Mesa, AZ

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 8 results; after an exact city/state check of listed facilities, 4 records were retained for Mesa, Arizona. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
Mesa, Arizona
Exact-location inclusion rule
A listed facility city and state must match Mesa, Arizona.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
1 record
NOT_YET_RECRUITING
1 record
ACTIVE_NOT_RECRUITING
2 records
ENROLLING_BY_INVITATION
0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 4 exact-location records and 4 listed facilities. All 4 retained records are shown below.

NCT07662213

Registry title: A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • Research SiteMesa, Arizona 85213

NCT06864026

Registry title: A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - MesaMesa, Arizona 85210

NCT07220629

Registry title: Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Investigative SiteMesa, Arizona 85225

NCT05556512

Registry title: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Aventiv ResearchMesa, Arizona 85206

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 8 results. After an exact city/state check of listed facilities, 4 records were retained for Mesa, Arizona, across 4 listed facilities. All 4 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
8
Exact-location records retained
4
Listed facilities retained
4
Records shown
4 of 4

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.